Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agnico Eagle Mines Ltd (AEM) vs Sana Biotechnology Inc (SANA) Price & Performance

Agnico Eagle Mines LtdTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Agnico Eagle Mines Ltd vs Sana Biotechnology Inc — how do they compare? Agnico Eagle Mines Ltd trades at $186.55 (market cap $92.01B), while Sana Biotechnology Inc trades at $3.77 (market cap $1.13B). The key difference: Agnico Eagle Mines Ltd is far larger — about 81.4× Sana Biotechnology Inc's market cap, and Agnico Eagle Mines Ltd pays a 0.99% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

AEMSANA
Market Cap
$92.01B$1.13B
Sector
Basic MaterialsHealth
52-Week High
$252.19$5.92
52-Week Low
$130.23$2.68
Enterprise Value
$88.85B$1.05B
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agnico Eagle Mines Ltd

Agnico Eagle Mines (AEM) trades at $185.82, up 2.96% on the day, reflecting strong momentum amid record gold prices and robust earnings. The stock exhibits a bullish technical setup with support near $180 and resistance at $186, while fundamentals are supported by a 37.5% net income margin and consistent earnings beats. Recent news highlights operational strength, with Q2 2026 EPS of $3.05 surpassing estimates and management projecting 20-30% production growth organically.

Outlook remains positive given analyst consensus and gold's uptrend, but rising unit costs and production challenges pose risks. With a $219.63 average price target implying 18% upside, AEM offers growth exposure to gold, though investors should monitor cost inflation and execution of expansion plans.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.

The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agnico Eagle Mines Ltd

Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.

Read more on AEM

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA